Does LEVOLEUCOVORIN Cause Malignant neoplasm progression? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Malignant neoplasm progression have been filed in association with LEVOLEUCOVORIN (Levoleucovorin). This represents 1.1% of all adverse event reports for LEVOLEUCOVORIN.
34
Reports of Malignant neoplasm progression with LEVOLEUCOVORIN
1.1%
of all LEVOLEUCOVORIN reports
13
Deaths
14
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LEVOLEUCOVORIN?
Of the 34 reports, 13 (38.2%) resulted in death, 14 (41.2%) required hospitalization, and 1 (2.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOLEUCOVORIN. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOLEUCOVORIN Cause?
Diarrhoea (302)
Nausea (274)
Neutropenia (246)
Decreased appetite (223)
Neuropathy peripheral (178)
Neutrophil count decreased (176)
Pyrexia (175)
Vomiting (167)
Febrile neutropenia (130)
Off label use (125)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LEVOLEUCOVORIN Alternatives Have Lower Malignant neoplasm progression Risk?
LEVOLEUCOVORIN vs LEVOMEPROMAZINE
LEVOLEUCOVORIN vs LEVOMETHADONE
LEVOLEUCOVORIN vs LEVOMILNACIPRAN
LEVOLEUCOVORIN vs LEVONORGESTREL
LEVOLEUCOVORIN vs LEVORPHANOL